Bausch Health Companies Inc. (BHC) Revenue History
Annual and quarterly revenue from 1993 to present
BHC Revenue Over Time (1993–2025)
BHC Revenue Growth History
25 of 32 years with positive growth- FY1993 revenue growth
- N/A
- FY1994 revenue growth
- +55.9%
- FY1995 revenue growth
- +19.1%
- FY1996 revenue growth
- +222.3%
- FY1997 revenue growth
- +24.1%
- FY1998 revenue growth
- +36.9%
- FY1999 revenue growth
- +56.5%
- FY2000 revenue growth
- +75.2%
- FY2001 revenue growth
- +88.7%
- FY2002 revenue growth
- +35.1%
- FY2003 revenue growth
- +4.5%
- FY2004 revenue growth
- +7.6%
- FY2005 revenue growth
- +5.5%
- FY2006 revenue growth
- +14.4%
- FY2007 revenue growth
- -21.3%
- FY2008 revenue growth
- -10.2%
- FY2009 revenue growth
- +8.4%
- FY2010 revenue growth
- +39.7%
- FY2011 revenue growth
- +114.9%
- FY2012 revenue growth
- +41.3%
- FY2013 revenue growth
- +65.7%
- FY2014 revenue growth
- +42.2%
- FY2015 revenue growth
- +27.3%
- FY2016 revenue growth
- -7.4%
- FY2017 revenue growth
- -9.8%
- FY2018 revenue growth
- -3.9%
- FY2019 revenue growth
- +2.6%
- FY2020 revenue growth
- -6.7%
- FY2021 revenue growth
- +5.1%
- FY2022 revenue growth
- -3.7%
- FY2023 revenue growth
- +7.8%
- FY2024 revenue growth
- +9.9%
- FY2025 revenue growth
- +8.5%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $2.49B | +10.5% |
| Q4 2025 | $2.84B | +10.9% |
| Q3 2025 | $2.65B | +5.6% |
| Q2 2025 | $2.57B | +7.1% |
| Q1 2025 | $2.25B | +4.6% |
| Q4 2024 | $2.56B | +6.3% |
| Q3 2024 | $2.51B | +12.2% |
| Q2 2024 | $2.40B | +10.9% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
BHC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
BHC Revenue Analysis (1993–2025)
Current Revenue & Growth
As of June 22, 2026, Bausch Health Companies Inc. (BHC) generated trailing twelve-month (TTM) revenue of $10.55 billion, reflecting strong growth of +10.5% year-over-year. The most recent quarter (Q1 2026) recorded $2.49 billion in revenue, down 12.3% sequentially.
Historical Growth Trajectory
BHC's 5-year compound annual growth rate (CAGR) stands at +5.4%, indicating steady revenue expansion. The 3-year CAGR of +8.7% exceeds the 5-year average, indicating an acceleration in the most recent period. Bausch Health Companies Inc.'s highest annual revenue of $10.45 billion was recorded in 2025, an all-time high.
Revenue by Segment
BHC's revenue is primarily driven by Product (49%), Pharmaceutical Products (23%), and Device Products (12%). The diversified mix across segments reduces dependence on any single product line, which can support more resilient revenue in downturns.
Peer Comparison
Compared to Healthcare sector peers — including PBH (-4.3% YoY), PRGO (-3.6% YoY), and BLCO (+7.8% YoY) — BHC has outperformed the peer group in revenue growth. Compare BHC vs PBH →
BHC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BHCCurrent | $10.6B | +10.5% | +5.4% | 21.3% | |
 PBH | $1.1B | -4.3% | +2.9% | 28.4% | |
 PRGO | $4.3B | -3.6% | +0.8% | 8.1% | |
 BLCO | $5.1B | +7.8% | +8.4% | 3.7% | |
 COO | $4.1B | +6.1% | +11.0% | 16.7% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% |
BHC Historical Revenue Data (1993–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $10.45B | +8.5% | $6.36B | 60.9% | $2.22B | 21.3% |
| 2024 | $9.63B | +9.9% | $6.84B | 71.1% | $1.55B | 16.1% |
| 2023 | $8.76B | +7.8% | $6.20B | 70.8% | $963.0M | 11.0% |
| 2022 | $8.12B | -3.7% | $5.76B | 70.9% | $454.0M | 5.6% |
| 2021 | $8.43B | +5.1% | $6.04B | 71.6% | $450.0M | 5.3% |
| 2020 | $8.03B | -6.7% | $5.78B | 72.0% | $676.0M | 8.4% |
| 2019 | $8.60B | +2.6% | $6.25B | 72.7% | $-203,000,000 | -2.4% |
| 2018 | $8.38B | -3.9% | $6.03B | 71.9% | $-2,384,000,000 | -28.4% |
| 2017 | $8.72B | -9.8% | $6.18B | 70.8% | $102.0M | 1.2% |
| 2016 | $9.67B | -7.4% | $7.10B | 73.4% | $-566,000,000 | -5.9% |
| 2015 | $10.44B | +27.3% | $8.00B | 76.6% | $1.53B | 14.6% |
| 2014 | $8.20B | +42.2% | $6.00B | 73.1% | $2.00B | 24.4% |
| 2013 | $5.77B | +65.7% | $4.24B | 73.5% | $-409,502,000 | -7.1% |
| 2012 | $3.48B | +41.3% | $2.59B | 74.4% | $79.7M | 2.3% |
| 2011 | $2.46B | +114.9% | $1.74B | 70.5% | $525.3M | 21.3% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
33+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BHC — Frequently Asked Questions
Quick answers to the most common questions about buying BHC stock.
Is BHC's revenue growth accelerating or slowing?
BHC revenue growth is holding steady at +10.5% year-over-year. TTM revenue is $10.6B. The current growth rate closely tracks the 5-year CAGR of +5.4%, signalling consistent execution.
What is BHC's revenue history from 1993 to 2026?
Bausch Health Companies Inc. (BHC) revenue history spans 1993 to 2026. TTM revenue as of 2026 is $10.6B, growing at +10.5% YoY. The 5-year CAGR is +5.4%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is BHC's long-term revenue growth rate (CAGR)?
Bausch Health Companies Inc.'s 5-year revenue CAGR of +5.4% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +10.5% is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for BHC.
Why does BHC's quarterly revenue fluctuate?
BHC quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Bausch Health Companies Inc.'s revenue data from 1993 to 2026 shows full historical quarterly detail on this page.
How is BHC's revenue distributed by segment?
BHC reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does BHC's revenue compare to industry peers?
Bausch Health Companies Inc. (BHC) with TTM revenue of $10.6B and +10.5% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.